JNJ
Johnson & Johnson · Healthcare · Drug Manufacturers - General
Momentum-inputs (vergelijkbare managers):
breedte van houders -4.3% ·
aandelenstroom -3.3% ·
netto nieuwe posities -4.5%
· formule
Brede distributie: dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q1 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 12.70M | $3.29B | n/a | −2 |
| Q2 2026 | 181 | +1 | 1.42B | $361.32B | +5 | −5 |
| Q1 2026 | 184 | 0 | 1.43B | $348.29B | +4 | −5 |
| Q4 2025 | 183 | 0 | 1.52B | $314.40B | +2 | −1 |
| Q3 2025 | 28 | 0 | 887.20M | $164.46B | n/a | −1 |
| Q2 2025 | 26 | +1 | 740.96M | $113.15B | +1 | n/a |
| Q1 2025 | 22 | -1 | 281.15M | $46.60B | n/a | −1 |
| Q4 2024 | 23 | +3 | 290.64M | $42.01B | +3 | n/a |
| Q3 2024 | 19 | -2 | 157.55M | $25.50B | n/a | −2 |
| Q2 2024 | 21 | n/a | 161.11M | $23.53B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passief) | 133.79M | -0.5% | $22.19B | 0.9% | ▼ Trim | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passief) | 59.38M | +3.0% | $9.83B | 0.8% | ▲ Add | 4 | SEC ↗ ×2 |
| 3 | Norges Bank ✦ (passief) | 30.81M | +1.5% | $5.11B | 0.7% | ▲ Add | 4 | SEC ↗ |
| 4 | Wellington Management ✦ | 22.65M | -7.0% | $3.76B | 0.7% | ▼ Trim | 4 | SEC ↗ ×8 |
| 5 | T. Rowe Price ✦ | 10.11M | -37.9% | $1.68B | 0.2% | ▼ Trim | 4 | SEC ↗ ×2 |
| 6 | Fisher Asset Management ✦ | 8.71M | +6.3% | $1.44B | 0.6% | ▲ Add | 4 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 5.27M | +51.6% | $873.27M | 0.9% | ▲ Add | 4 | SEC ↗ ×7 |
| 8 | Arrowstreet Capital ✦ | 3.30M | +39.5% | $547.50M | 0.4% | ▲ Add | 4 | SEC ↗ |
| 9 | Adage Capital Partners ✦ | 1.28M | +36.8% | $212.01M | 0.4% | ▲ Add | 4 | SEC ↗ |
| 10 | Millennium Management ✦ | 1.25M | -28.2% | $207.97M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 1.17M | +20.8% | $194.69M | 0.2% | ▲ Add | 4 | SEC ↗ ×2 |
| 12 | Marshall Wace ✦ | 912.88K | -77.5% | $151.39M | 0.2% | ▼ Trim | 4 | SEC ↗ ×3 |
| 13 | Citadel Advisors ✦ | 664.02K | -64.4% | $110.12M | 0.1% | ▼ Trim | 4 | SEC ↗ ×2 |
| 14 | Markel Group ✦ | 610.80K | 0.0% | $101.30M | 0.9% | Held | 4 | SEC ↗ ×2 |
| 15 | Tweedy, Browne ✦ | 438.27K | -59.4% | $72.68M | 6.4% | ▼ Trim | 4 | SEC ↗ |
| 16 | Bridgewater Associates ✦ | 297.29K | -44.7% | $49.30M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 17 | Renaissance Technologies ✦ | 202.56K | -78.0% | $33.59M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 98.43K | -50.6% | $16.32M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 19 | GAMCO Investors ✦ | 86.71K | -6.7% | $14.38M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 20 | Fairfax Financial ✦ | 73.40K | 0.0% | $12.18M | 0.7% | Held | 4 | SEC ↗ |
| 21 | Two Sigma Investments ✦ | 23.96K | -62.4% | $3.97M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 22 | Dodge & Cox ✦ | 21.10K | 0.0% | $3.50M | 0.0% | Held | 4 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Point72 Asset Management | $44.21M | was 0.1% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1 houders, 136.10K aandelen, $33,268 gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 11.07K aand · $3.04M
Officer · 22.53K aand · $6.19M
Officer · 15.00K aand · $3.95M
Officer, Director · 102.31K aand · $26.70M
Officer, Director · 20.98K aand · $5.50M
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie